MONITORING OF GENE EXPRESSION IN TACROLIMUS-TREATED DE NOVO RENAL ALLOGRAFT RECIPIENTS FACILITATES INDIVIDUALIZED IMMUNOSUPPRESSION - RESULTS OF THE IMAGEN STUDY

被引：0
|
作者：
Sommerer, C. [1 ]
Millan, O. [2 ]
Glander, P. [3 ]
Brunet, M. [2 ]
Guirado Perich, L. [4 ]
Budde, K. [3 ]
Meuer, S. [5 ]
Zeier, M. [1 ]
Giese, T. [5 ]
机构：
[1] Univ Hosp Heidelberg, Nephrol, Heidelberg, Germany
[2] Hosp Clin Barcelona, Pharmacol & Toxicol Lab, Barcelona, Spain
[3] Charite, Nephrol, Berlin, Germany
[4] Fundacio Puigvert Barcelona, Renal Transplant Unit, Barcelona, Spain
[5] Univ Hosp Heidelberg, Immunol, Heidelberg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2020年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
S24-03
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [21] EVEROLIMUS WITH LOW OR VERY LOW EXPOSURE OF TACROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS: THE ASSET STUDY
    Vitko, Stefan
    Hene, Ronald
    Langer, Robert
    Christiaans, Maarten
    Tedesco, Helio
    Ciechanowski, Kazimierz
    Cassuto, Elizabeth
    Rostaing, Lionel
    Vilatoba, Mario
    Pascual, Julio
    TRANSPLANT INTERNATIONAL, 2009, 22 : 53 - 53
  • [22] Renal Function and NODM in De Novo Renal Transplant Recipients Treated with Standard and Reduced Levels of Tacrolimus in Combination with EC-MPS
    Chan, Laurence
    Andres, Amado
    Bunnapradist, Suphamai
    Gugliuzza, Kristene
    Parasuraman, Ravi
    Peddi, V. Ram
    Cassuto, Elisabeth
    Hart, Marquis
    JOURNAL OF TRANSPLANTATION, 2012, 2012
  • [23] Long term results of de novo kidney transplant recipients treated with the combination of low dose Tacrolimus and Everolimus.
    Silvestri, Patrizia
    Salerno, Maria Paola
    Zanoni, Natalia
    Spagnoletti, Gionata
    Citterio, Franco
    TRANSPLANTATION, 2024, 108 (09) : 252 - 252
  • [24] Long term results of de novo kidney transplant recipients treated with the combination of low dose Tacrolimus and Everolimus.
    Silvestri, Patrizia
    Paola Salerno, Maria
    Zanoni, Natalia
    Spagnoletti, Gionata
    Citterio, Franco
    TRANSPLANTATION, 2024, 108 (9S)
  • [25] Allograft Function after 12 Months with Everolimus Plus Either Tacrolimus or Cyclosporine Compared to a Standard Regimen of Tacrolimus with MPA in De Novo Renal Transplant Recipients: The ATHENA Study.
    Nashan, B.
    Sommerer, C.
    Suwelack, B.
    Dragun, D.
    Witzke, O.
    Hugo, C.
    Kamar, N.
    Merville, P.
    Hauser, A.
    Schenker, P.
    Junge, M.
    Thaiss, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 260 - 260
  • [26] De Novo Anti-HLA Antibodies in Renal Allograft Recipients: A Cross-Section Study
    Sanchez-Fructuoso, A. I.
    Santiago, J. L.
    Perez-Flores, I.
    Calvo Romero, N.
    Valero, R.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (08) : 2874 - 2876
  • [27] DE-NOVO CANCER IN CYCLOSPORINE-TREATED AND NON-CYCLOSPORINE-TREATED ADULT PRIMARY RENAL-ALLOGRAFT RECIPIENTS
    GRUBER, SA
    GILLINGHAM, K
    SOTHERN, RB
    STEPHANIAN, E
    MATAS, AJ
    DUNN, DL
    CLINICAL TRANSPLANTATION, 1994, 8 (04) : 388 - 395
  • [28] Everolimus immunosuppression for renal protection, reduction of allograft vasculopathy and prevention of allograft rejection in de-novo heart transplant recipients: could we have it all?
    Gude, Einar
    Gullestad, Lars
    Andreassen, Arne K.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2017, 22 (03) : 198 - 206
  • [29] Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients
    Thervet, E
    Anglicheau, D
    Toledano, N
    Houllier, AM
    Noel, LH
    Kreis, H
    Beaune, P
    Legendre, C
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2001, 12 (01): : 170 - 176
  • [30] PRESERVING RENAL FUNCTION WITH PROLONGED-RELEASE TACROLIMUS-BASED IMMUNOSUPPRESSION IN DE NOVO LIVER TRANSPLANTATION: INITIAL RESULTS FROM THE DIAMOND STUDY
    Trunecka, Pavel
    Klempnauer, Juergen
    Tisone, Giuseppe
    TRANSPLANT INTERNATIONAL, 2013, 26 : 171 - 171
12345